Business

Actinogen secures $4.3m of non-dilutive R&D tax funding

Actinogen secures $4.3m of non-dilutive R&D tax funding

Actinogen Medical LimitedJanuary 26, 20263
Actinogen secures $4.3m of non-dilutive R&D tax funding

About this update from Actinogen Medical Limited

Actinogen Medical Ltd has released a press release. View Attachment

View stock analysis, news, and events for Actinogen Medical Limited

More from Actinogen Medical Limited

All Actinogen Medical Limited news →